NCT02254083View on ClinicalTrials.gov

Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

May 31, 2003

Conditions
Healthy
Interventions
DRUG

BIBT 986 BS - low

DRUG

BIBT 986 BS - high

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY